Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 11
2003 2
2004 7
2005 5
2006 6
2007 7
2008 7
2009 7
2010 11
2011 11
2012 12
2013 8
2014 7
2015 8
2016 9
2017 5
2018 2
2019 5
2020 8
2021 4
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Counteracting CAR T cell dysfunction.
Poorebrahim M, Melief J, Pico de Coaña Y, L Wickström S, Cid-Arregui A, Kiessling R. Poorebrahim M, et al. Among authors: kiessling r. Oncogene. 2021 Jan;40(2):421-435. doi: 10.1038/s41388-020-01501-x. Epub 2021 Jan 14. Oncogene. 2021. PMID: 33168929 Free PMC article. Review.
Genetically modified immune cells targeting tumor antigens.
Poorebrahim M, Abazari MF, Sadeghi S, Mahmoudi R, Kheirollahi A, Askari H, Wickström SL, Poortahmasebi V, Lundqvist A, Kiessling R, Cid-Arregui A. Poorebrahim M, et al. Among authors: kiessling r. Pharmacol Ther. 2020 Oct;214:107603. doi: 10.1016/j.pharmthera.2020.107603. Epub 2020 Jun 15. Pharmacol Ther. 2020. PMID: 32553789 Free article. Review.
Classification of current anticancer immunotherapies.
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G. Galluzzi L, et al. Among authors: kiessling r. Oncotarget. 2014 Dec 30;5(24):12472-508. doi: 10.18632/oncotarget.2998. Oncotarget. 2014. PMID: 25537519 Free PMC article. Review.
Interleukin-33 is a Novel Immunosuppressor that Protects Cancer Cells from TIL Killing by a Macrophage-Mediated Shedding Mechanism.
Wu J, Chen Z, Wickström SL, Gao J, He X, Jing X, Wu J, Du Q, Yang M, Chen Y, Zhang D, Yin X, Guo Z, Jensen L, Yang Y, Tao W, Lundqvist A, Kiessling R, Cao Y. Wu J, et al. Among authors: kiessling r. Adv Sci (Weinh). 2021 Nov;8(21):e2101029. doi: 10.1002/advs.202101029. Epub 2021 Sep 5. Adv Sci (Weinh). 2021. PMID: 34486239 Free PMC article.
Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells.
Eisinger S, Sarhan D, Boura VF, Ibarlucea-Benitez I, Tyystjärvi S, Oliynyk G, Arsenian-Henriksson M, Lane D, Wikström SL, Kiessling R, Virgilio T, Gonzalez SF, Kaczynska D, Kanatani S, Daskalaki E, Wheelock CE, Sedimbi S, Chambers BJ, Ravetch JV, Karlsson MCI. Eisinger S, et al. Among authors: kiessling r. Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32005-32016. doi: 10.1073/pnas.2015343117. Epub 2020 Nov 23. Proc Natl Acad Sci U S A. 2020. PMID: 33229588 Free PMC article.
Serendipity. Coincidence. Luck.
Kiessling R. Kiessling R. Crit Rev Oncog. 2014;19(1-2):15-9. doi: 10.1615/critrevoncog.2014011099. Crit Rev Oncog. 2014. PMID: 25199215 Review. No abstract available.
Regulatory T cells in cancer.
Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC. Mougiakakos D, et al. Among authors: kiessling r. Adv Cancer Res. 2010;107:57-117. doi: 10.1016/S0065-230X(10)07003-X. Adv Cancer Res. 2010. PMID: 20399961 Review.
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.
Neo SY, Tong L, Chong J, Liu Y, Jing X, Oliveira MMS, Chen Y, Chen Z, Lee K, Burduli N, Chen X, Gao J, Ma R, Lim JP, Huo J, Xu S, Alici E, Wickström SL, Haglund F, Hartman J, Wagner AK, Cao Y, Kiessling R, Lam KP, Westerberg LS, Lundqvist A. Neo SY, et al. Among authors: kiessling r. Sci Transl Med. 2024 May 15;16(747):eadi2952. doi: 10.1126/scitranslmed.adi2952. Epub 2024 May 15. Sci Transl Med. 2024. PMID: 38748775
Cellular immunity to the Her-2/neu protooncogene.
Kiessling R, Wei WZ, Herrmann F, Lindencrona JA, Choudhury A, Kono K, Seliger B. Kiessling R, et al. Adv Cancer Res. 2002;85:101-44. doi: 10.1016/s0065-230x(02)85004-7. Adv Cancer Res. 2002. PMID: 12374283 Review.
133 results